{"DataElement":{"publicId":"5566107","version":"2","preferredName":"Acute Leukemia of Ambiguous Lineage And Other Myeloid Neoplasm Disease or Disorder Classification Type","preferredDefinition":"A description of the acute leukemia of ambiguous lineage and other myeloid neoplasm disease or disorder classification.","longName":"5566082v1.00:5566085v1.10","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5566082","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage And Other Myeloid Neoplasm Disease or Disorder Classification","preferredDefinition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001)_An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Different than the one(s) previously specified or mentioned._Diseases in which too many blood cells are made in the bone marrow._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"5566080v1.0:2321361v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5566080","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage And Other Myeloid Neoplasm Disease or Disorder","preferredDefinition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001):An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:Different than the one(s) previously specified or mentioned.:Diseases in which too many blood cells are made in the bone marrow.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"5566080v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Leukemia of Ambiguous Lineage","conceptCode":"C7464","definition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Myeloid Neoplasm","conceptCode":"C9290","definition":"Proliferation of myeloid cells originating from a primitive stem cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"406B32E1-581A-0E18-E053-F662850A0F54","latestVersionIndicator":"Yes","beginDate":"2016-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-03","modifiedBy":"ONEDATA","dateModified":"2016-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"406B32E1-5828-0E18-E053-F662850A0F54","latestVersionIndicator":"Yes","beginDate":"2016-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-03","modifiedBy":"NYCHM","dateModified":"2017-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5566085","version":"1.1","preferredName":"Acute Leukemia of Ambiguous Lineage And Other Myeloid Neoplasm Type","preferredDefinition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001)_An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Different than the one(s) previously specified or mentioned._A clonal (malignant) proliferation of myeloid cells originating from a primitive stem cell._Something distinguishable as an identifiable class based on common qualities.","longName":"5566085v1.10","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Blastic plasmacytoid dendritic cell neoplasm","valueDescription":null,"ValueMeaning":{"publicId":"5574401","version":"1","preferredName":"Blastic Plasmacytoid Dendritic Cell Neoplasm","longName":"5574401v1.00","preferredDefinition":"A clinically aggressive neoplasm derived from the precursors of plasmacytoid dendritic cells (also called professional type I interferon-producing cells or plasmacytoid monocytes), with a high frequency of cutaneous and bone marrow involvement and leukemic dissemination. (WHO 2017)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blastic Plasmacytoid Dendritic Cell Neoplasm","conceptCode":"C7203","definition":"A clinically aggressive neoplasm derived from the precursors of plasmacytoid dendritic cells (also called professional type I interferon-producing cells or plasmacytoid monocytes), with a high frequency of cutaneous and bone marrow involvement and leukemic dissemination. (WHO 2017)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41457D3D-7694-5F06-E053-F662850A638F","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-14","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7D9C-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Acute undifferentiated leukemia","valueDescription":null,"ValueMeaning":{"publicId":"4858051","version":"1","preferredName":"Acute Undifferentiated Leukemia","longName":"4858051v1.00","preferredDefinition":"A rare acute leukemia of ambiguous lineage in which the blasts do not express markers specific to myeloid or lymphoid lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Undifferentiated Leukemia","conceptCode":"C9298","definition":"A rare acute leukemia of ambiguous lineage in which the blasts do not express markers specific to myeloid or lymphoid lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1805D4A1-419B-4FE2-E050-BB89AD435E9B","latestVersionIndicator":"Yes","beginDate":"2015-06-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-06-08","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7D9D-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Mixed phenotype acute leukemia (MPAL) with BCR::ABL1 fusion","valueDescription":null,"ValueMeaning":{"publicId":"3322385","version":"1","preferredName":"Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion","longName":"3322385v1.00","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts carry the chromosomal translocation t(9;22)(q34.1;q11.2) that results in BCR-ABL1 gene fusion. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion","conceptCode":"C82192","definition":"A rare mixed phenotype acute leukemia in which the blasts carry the chromosomal translocation t(9;22)(q34.1;q11.2) that results in BCR-ABL1 gene fusion. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BB97-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7D9E-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Mixed phenotype acute leukemia with KMT2A rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"8123160","version":"1","preferredName":"Mixed Phenotype Acute Leukemia with KMT2A Rearrangement","longName":"8123160v1.00","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts carry a translocation between the KMT2A gene at 11q23.3 and another gene partner. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia with KMT2A Rearrangement","conceptCode":"C82203","definition":"A rare mixed phenotype acute leukemia in which the blasts carry a translocation between the KMT2A gene at 11q23.3 and another gene partner. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A261-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7D9F-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Mixed-phenotype acute leukemia with ZNF384 rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"8123159","version":"1","preferredName":"B Acute Lymphoblastic Leukemia with ZNF384 Rearrangement","longName":"8123159v1.00","preferredDefinition":"B-acute lymphoblastic leukemia associated with ZNF384 gene rearrangement. The prognosis is variable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia with ZNF384 Rearrangement","conceptCode":"C199234","definition":"B-acute lymphoblastic leukemia associated with ZNF384 gene rearrangement. The prognosis is variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A23E-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7DA0-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Acute leukemia of ambiguous lineage with BCL11B rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"14679033","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement","longName":"14679033v1.00","preferredDefinition":"A rare acute leukemia of ambiguous lineage characterized by the presence of BCL11B gene rearrangement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement","conceptCode":"C203437","definition":"A rare acute leukemia of ambiguous lineage characterized by the presence of BCL11B gene rearrangement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F12E748-293E-3E47-E063-731AD00AA4FF","latestVersionIndicator":"Yes","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7DA1-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Mixed-phenotype acute leukemia, B/myeloid","valueDescription":null,"ValueMeaning":{"publicId":"14679040","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, B/Myeloid","longName":"14679040v1.00","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, B/Myeloid","conceptCode":"C82212","definition":"A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F1375EC-7D9A-59FB-E063-731AD00A3D54","latestVersionIndicator":"Yes","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7DA2-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Mixed-phenotype acute leukemia, T/myeloid","valueDescription":null,"ValueMeaning":{"publicId":"8123158","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, T/Myeloid","longName":"8123158v1.00","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, T/Myeloid","conceptCode":"C82213","definition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A21B-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":"2023.9.5 Alt VM added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7DA3-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Mixed-phenotype acute leukemia, rare types","valueDescription":null,"ValueMeaning":{"publicId":"8123157","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, Rare Types","longName":"8123157v1.00","preferredDefinition":"A very rare mixed phenotype acute leukemia in which the blasts express combinations of B, T, myeloid, and megakaryocytic lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, Rare Types","conceptCode":"C151990","definition":"A very rare mixed phenotype acute leukemia in which the blasts express combinations of B, T, myeloid, and megakaryocytic lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A1F8-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":"2023.9.5 Alt VM added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7DA4-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"},{"value":"Acute leukemia of ambiguous lineage, not otherwise specified","valueDescription":null,"ValueMeaning":{"publicId":"14679041","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified","longName":"14679041v1.00","preferredDefinition":"Acute leukemia of ambiguous lineage, expressing combinations of markers that do not allow for its classification as either acute undifferentiated leukemia or mixed phenotype acute leukemia, and definitive classification along a single lineage is difficult. (WHO 2017)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified","conceptCode":"C151975","definition":"Acute leukemia of ambiguous lineage, expressing combinations of markers that do not allow for its classification as either acute undifferentiated leukemia or mixed phenotype acute leukemia, and definitive classification along a single lineage is difficult. (WHO 2017)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F1375EC-7D9B-59FB-E063-731AD00A3D54","latestVersionIndicator":"Yes","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1375EC-7DA5-59FB-E063-731AD00A3D54","beginDate":"2024-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5566084","version":"1","preferredName":"Acute Leukemia of Ambiguous Lineage And Other Myeloid Neoplasm Type","preferredDefinition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001):An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:Different than the one(s) previously specified or mentioned.:Diseases in which too many blood cells are made in the bone marrow.:Something distinguishable as an identifiable class based on common qualities.","longName":"5566084v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Leukemia of Ambiguous Lineage","conceptCode":"C7464","definition":"An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Myeloid Neoplasm","conceptCode":"C9290","definition":"Proliferation of myeloid cells originating from a primitive stem cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"406B39C3-AA20-3485-E053-F662850A7A92","latestVersionIndicator":"Yes","beginDate":"2016-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-03","modifiedBy":"ONEDATA","dateModified":"2016-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F1340FE-A9D8-5102-E063-731AD00A3F72","latestVersionIndicator":"Yes","beginDate":"2016-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"GDEEN","dateModified":"2024-02-12","changeDescription":". Added 2 PVs for another context. AK 6/21/18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TDIS_ALMN_lk_amb_lin_mye_neo","type":"NMDP_FN","context":"NHLBI"},{"name":"ALALSubcat","type":"COG GDE Short Name","context":"COG"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the acute leukemia of ambiguous lineage and other myeloid neoplasm disease or disorder classification?","url":null,"context":"NHLBI"},{"name":"Specify acute leukemias of ambiguous lineage and other myeloid neoplasm classification","type":"Alternate Question Text","description":"Specify acute leukemias of ambiguous lineage and other myeloid neoplasm classification","url":null,"context":"NHLBI"},{"name":"Specify acute leukemias of ambiguous lineage and other myeloid neoplasm classification","type":"Application Standard Question Text","description":"Specify acute leukemias of ambiguous lineage and other myeloid neoplasm classification","url":null,"context":"NHLBI"},{"name":"Acute Leukemia of Ambiguous Lineage  subcategory","type":"Alternate Question Text","description":"Acute Leukemia of Ambiguous Lineage  subcategory:","url":null,"context":"COG"},{"name":"NMDP Text 1","type":"Alternate Question Text","description":"Specify acute leukemias of mixed or ambiguous lineage","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"DRAFT MOD","registrationStatus":"Application","id":"0F13DFC8-ABE0-788D-E063-731AD00A9090","latestVersionIndicator":"Yes","beginDate":"2016-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-16","modifiedBy":"KUMMEROA","dateModified":"2024-02-13","changeDescription":".","administrativeNotes":"2024.2.13 AQT added per ticket request CADSR0003398. ak 2024.1.16 Created per ticket request CADSR0003263. ak","unresolvedIssues":null,"deletedIndicator":"No"}}